» Articles » PMID: 36555410

When Two Maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Dec 23
PMID 36555410
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke and cancer are disabling diseases with an enormous global burden, disproportionately affecting vulnerable populations and low- and middle-income countries. Both these diseases share common risk factors, which warrant concerted attention toward reshaping population health approaches and the conducting of fundamental studies. In this article, an overview of epidemiological trends in the prevalence and burden of cancer and stroke, underlying biological mechanisms and clinical risk factors, and various tools available for risk prediction and prognosis are provided. Finally, future recommendations for research and existing gaps in our understanding of pathophysiology. Further research must investigate the causes that predispose patients to an increased risk of stroke and/or cancer, as well as biomarkers that can be used to predict growing morbidity and mortality.

Citing Articles

An innovative approach to development of new pyrazolylquinolin-2-one hybrids as dual EGFR and BRAF inhibitors.

Hawwas M, Mancy A, Ramadan M, Ibrahim T, Bayoumi A, Alswah M Mol Divers. 2025; .

PMID: 40056327 DOI: 10.1007/s11030-025-11127-4.


Leukemia and risk of stroke: a Mendelian randomization analysis.

Yi X, Zhu J, Zhang X, Huang N, Cheng Y BMC Neurol. 2025; 25(1):68.

PMID: 39972428 PMC: 11837699. DOI: 10.1186/s12883-025-04079-7.


Decoding the Nexus: Cellular and Molecular Mechanisms Linking Stroke and Neurotoxic Microenvironments in Brain Cancer Patients.

Menounos S, Shen H, Tipirneni S, Bhaskar S Biomolecules. 2025; 14(12.

PMID: 39766214 PMC: 11673144. DOI: 10.3390/biom14121507.


Epigenetic age and long-term cancer risk following a stroke.

Suarez-Perez A, Macias-Gomez A, Fernandez-Perez I, Vallverdu-Prats M, Cuadrado-Godia E, Giralt-Steinhauer E Genome Med. 2024; 16(1):135.

PMID: 39578904 PMC: 11583382. DOI: 10.1186/s13073-024-01408-2.


Prospects of compounds of herbal plants as anticancer agents: a comprehensive review from molecular pathways.

Situmorang P, Ilyas S, Nugraha S, Syahputra R, Nik Abd Rahman N Front Pharmacol. 2024; 15:1387866.

PMID: 39104398 PMC: 11298448. DOI: 10.3389/fphar.2024.1387866.


References
1.
Blom J, Doggen C, Osanto S, Rosendaal F . Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005; 293(6):715-22. DOI: 10.1001/jama.293.6.715. View

2.
Mueller S, Fullerton H, Stratton K, Leisenring W, Weathers R, Stovall M . Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys. 2013; 86(4):649-55. PMC: 3696633. DOI: 10.1016/j.ijrobp.2013.03.034. View

3.
Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C . Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke. Br J Cancer. 2009; 100(5):811-6. PMC: 2653766. DOI: 10.1038/sj.bjc.6604902. View

4.
Rajkumar S, Hayman S, Gertz M, Dispenzieri A, Lacy M, Greipp P . Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. J Clin Oncol. 2002; 20(21):4319-23. DOI: 10.1200/JCO.2002.02.116. View

5.
Holmoy T, Nakstad P, Fredo H, Kumar T . Intravascular large B-cell lymphoma presenting as cerebellar and cerebral infarction. Arch Neurol. 2007; 64(5):754-5. DOI: 10.1001/archneur.64.5.754. View